Full‐active pharmaceutical ingredient nanosensitizer for augmented photoimmunotherapy by synergistic mitochondria targeting and immunogenic death inducing
MedComm · 2024-11 · 5 (11)
DOI: 10.1002/mco2.756 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 09.11.2024. Verfasst von Xianghui Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology The First Affiliated Hospital of Guangxi Medical University Nanning China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The precise and effective activation of the immune response is crucial in promising therapy curing cancer. Photoimmunotherapy (PIT) is an emerging strategy for precise regulation and highly spatiotemporal selectivity. However, this approach faces a significant challenge due to the off‐target effect and the immunosuppressive microenvironment. To address this challenge, a nanoscale full‐active pharmaceutical ingredient (API) photo‐immune stimulator was developed. This formulation overcomes the limitations of PIT by strengthening the ability to penetrate tumors deeply and inducing precise and potent mitochondria‐targeted dual‐mode photodynamic therapy and photothermal therapy. Along with inhibiting overexpressed Hsp90, this nanosensitizer in turn improves the immunosuppressive microenvironment. Ultimately, this mitochondria‐targeted PIT demonstrated potent antitumor efficacy, achieving a remarkable inhibition rate of ≥95% for both established primary tumors and distant abscopal tumors. In conclusion, this novel self‐delivery full‐API nanosystem enhances the efficacy of phototherapy and reprograms the immunosuppressive microenvironment, thereby holding great promise in the development of precise and effective immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology The First Affiliated Hospital of Guangxi Medical University Nanning China.
- Department of Gastrointestinal Surgery Affiliated Nanjing Drum Tower Hospital Nanjing University Medical School Nanjing China.
- State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture Nanjing University of Chinese Medicine Nanjing China.
ORCID-Profile: Xianghui Li, Haoran Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangxi Province
- Youth Science Foundation of Guangxi Medical University
Zitieren
APA
Li, X., Wang, H., Li, Z., Liu, S., Chen, Y., Ruan, Z., Yao, Z., Wei, G., Cao, C., Zheng, W., & Guan, W. (2024). Full‐active pharmaceutical ingredient nanosensitizer for augmented photoimmunotherapy by synergistic mitochondria targeting and immunogenic death inducing. MedComm, 5(11). https://doi.org/10.1002/mco2.756
Vancouver
Li X, Wang H, Li Z, Liu S, Chen Y, Ruan Z, et al. Full‐active pharmaceutical ingredient nanosensitizer for augmented photoimmunotherapy by synergistic mitochondria targeting and immunogenic death inducing. MedComm. 2024;5(11). doi:10.1002/mco2.756
BibTeX
@article{Li2024,
author = {Li, Xianghui and Wang, Haoran and Li, Zhiyan and Liu, Song and Chen, Yuanyuan and Ruan, Zhuren and Yao, Zhijian and Wei, Gao and Cao, Cunwei and Zheng, Wenjun and Guan, Wenxian},
title = {Full‐active pharmaceutical ingredient nanosensitizer for augmented photoimmunotherapy by synergistic mitochondria targeting and immunogenic death inducing},
journal = {MedComm},
year = {2024},
volume = {5},
number = {11},
doi = {10.1002/mco2.756}
}
EUVIMED